Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
The USFDA has issued 5 observations pursuant to the completion of audit
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Longest survival follow-up ever reported for immunotherapy treatment in this setting
US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
Global Phase-3 study initiation expected in the second half of 2024
Subscribe To Our Newsletter & Stay Updated
